Form 8-K - Current report:
SEC Accession No. 0001193125-25-017264
Filing Date
2025-01-30
Accepted
2025-01-30 16:16:51
Documents
13
Period of Report
2025-01-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d913894d8k.htm   iXBRL 8-K 25306
  Complete submission text file 0001193125-25-017264.txt   146986

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20250124.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20250124_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20250124_pre.xml EX-101.PRE 11261
15 EXTRACTED XBRL INSTANCE DOCUMENT d913894d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 25573955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)